 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.

Current Price	$3.19
Prev Close	$3.20
Open	$3.20
Dividend Yield	0.00%
50-Day Moving Average	$2.81
Beta	1.03
Avg. Volume	206,703.47
PE Ratio	30.09

52-Week High	$5.16
52-Week Low	$1.79
Market Capitalization	$149M
EPS	$0.106
Price to Book	5.76
Revenue Per Employee	$1.22M
Enterprise Value/EBITDA	4.14

PBYI Puma Biotechnology Inc

About

Feed

Fundamentals

News